A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease

Clinical trial NCT03270956 · COMPLETED

Trial details

NCT number: NCT03270956
Sponsor: Prokidney
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus Chronic Kidney Disease

Start date: 2018-04-25
Primary completion: 2022-11-17
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.